Krystal Biotech Says EMA Validated MAA For VYJUVEK For Dystrophic Epidermolysis Bullosa

RTTNews | Pred 563 dňami
Krystal Biotech Says EMA Validated MAA For VYJUVEK For Dystrophic Epidermolysis Bullosa

(RTTNews) - Biotechnology company Krystal Biotech, Inc. (KRYS) announced Monday that the Company's Marketing Authorization Application (MAA) to the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) for VYJUVEK (beremagene geperpavec-svdt or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB) has been validated and is now under CHMP review. A CHMP opinion is anticipated in the second half of 2024.

In September 2023, Krystal Biotech received a positive opinion from the EMA Pediatric Committee on the Pediatric Investigation Plan for VYJUVEK for the treatment of DEB.

Based on this positive opinion, the Company would be eligible for up to an additional two years of marketing exclusivity in the EU, on top of the ten-year EU market exclusivity after market approval in the EU.

Previously, VYJUVEK received Orphan Drug Designation and PRIority Medicines (PRIME) eligibility from the EMA.

read more
European Shares Set For Gap-down Open

European Shares Set For Gap-down Open

European shares are seen opening sharply lower on Friday as trade uncertainties and escalating geopolitical tensions sparked flight to safety.
RTTNews | Pred 39 minútami
European Economic News Preview: Eurozone Industrial Output, Trade Data Due

European Economic News Preview: Eurozone Industrial Output, Trade Data Due

Industrial production and foreign trade from the euro area and final inflation figures from Germany and France are the top economic news due on Friday. At 2.00 am ET, Destatis is scheduled to issue Germany's final consumer and harmonized prices and wholesale prices for May. The flash estimate showed that consumer price inflation remained unchanged at 2.1 percent.
RTTNews | Pred 1 h 26 min
Australian Market Doubles Early Losses In Mid-market

Australian Market Doubles Early Losses In Mid-market

The Australian stock market is doubling its early loses in mid-market moves on Friday, extending the losses in the previous session, despite the broadly positive cues from Wall Street overnight. The benchmark S&P/ASX 200 is falling below the 8,550 level, with weakness is technology stocks partially offset by gains in gold miners and energy stocks.
RTTNews | Pred 3 h 0 min
Asian Markets A Sea Of Red

Asian Markets A Sea Of Red

Asian stock markets are a sea of red on Friday, despite the broadly positive cues from Wall Street overnight, amid heightening geopolitical tensions in the Middle East region after Israel launched a preemptive strike against Iran in a major escalation of the regional conflict. US officials confirmed that the U.S. had no involvement or role in the operation. Asian markets ended mixed on Thursday.
RTTNews | Pred 3 h 18 min